In 2001, Gleevec was approved as a treatment for chronic myelogenous leukemia. It was a revelation for personalized medicine—with harrowing financial repercussions that persist today.
via Tingle Tech
-
Dukaan, a one-year-old Bangalore-based startup that enables merchants to set up online stores and sell products digitally, said on Monday it...
-
German startup Dance is launching its subscription service in its hometown Berlin. For a flat monthly fee of €79 (around $93 at today’s exc...
-
The Station is a weekly newsletter dedicated to all things transportation. Sign up here — just click The Station — to receive it every week...